|
Canada-0-PESTICIDES Azienda Directories
|
Azienda News:
- Drug Approvals and Databases | FDA
Downloadable data files FDA Adverse Event Reporting System (FAERS) Public Dashboard Inactive Ingredient Search for Approved Drug Products Search More information Medication Guides Search More
- FDA-Approved Treatments for Alzheimers
FDA-Approved Drugs For Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia
- New FDA Drug Approvals for 2026 - Drugs. com
Up to date information on the latest FDA drug approvals Includes list of most recent approvals, the conditions approved for, and the approval history
- FDA approves Denali Hunter syndrome drug - fiercepharma. com
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease after a string of high-profile rejections for rare disease candidates In approving
- UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA . . .
"The FDA approval of UPLIZNA marks a significant turning point for IgG4-RD patients and physicians who now have a proven treatment that targets a key driver of the disease, reducing the risk of flares and reliance on harmful long-term steroid use," said Jay Bradner, M D , executive vice president of Research and Development at Amgen
- March 2026: Notable Drug Approvals - Infectious Disease Advisor
View all the drugs approved by the Food and Drug Administration in March 2026
- FDA Approves Ozempic For Type 2 Diabetes and Chronic Kidney . . .
On January 28, 2025, the U S Food and Drug Administration (FDA) approved Ozempic for use in people with type 2 diabetes and kidney disease This approval marks an important milestone in kidney disease treatment, offering a new option to help reduce complications like heart disease, dialysis, or kidney transplant
- Novel Drug Approvals for 2025 | FDA
FDA Novel Drug Therapy Approvals for 2025 In 2025, CDER approved 46 new drugs never before approved or marketed in the U S , known as “novel” drugs
- FDA approves Wellcovorin for ultra-rare disease. The Trump . . .
The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same
- Vyalev: A Newly-Approved Medication for Parkinson’s Disease . . .
While carbidopa-levodopa is not a new medication, new formulations of it give people with Parkinson’s disease more options to customize treatment and increase quality of life It is early days for implementing this new treatment and the processes for getting started are unfolding
|
|